Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DEVON S MCKENZIE

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1497152888
CMS profile
7109233
Location
EGG HARBOR TOWNSHIP, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,998.11

120 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,998.11 120

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 120 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DEVON S MCKENZIE

NPI 1497152888 · CMS profile ID 7109233

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

EGG HARBOR TOWNSHIP, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 120 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1497152888?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DEVON S MCKENZIE, NPI 1497152888, CMS profile ID 7109233. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 120 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1497152888?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). DEVON S MCKENZIE, NPI 1497152888, CMS profile ID 7109233. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 120 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1497152888?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
DEVON S MCKENZIE, NPI 1497152888, CMS profile ID 7109233, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 120 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1497152888?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

120 matching records · $1,998.11 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 120 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 120.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Eisai Inc. $19.1307/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023308139 CMS
Regeneron Healthcare Solutions, Inc. $22.7107/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999295779 CMS
E.R. Squibb & Sons, L.L.C. $14.3507/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323923 CMS
MorphoSys, US Inc. $16.5307/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060326209 CMS
Daiichi Sankyo Inc. $18.0207/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006407077 CMS
E.R. Squibb & Sons, L.L.C. $16.1707/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323915 CMS
Eisai Inc. $17.9207/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023308141 CMS
Celgene Corporation $15.0907/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323907 CMS
Genmab U.S., Inc. $14.6207/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343989 CMS
Amgen Inc. $14.9906/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019892995 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.8506/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055483583 CMS
Genentech USA, Inc. $14.8306/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040348503 CMS
Pharmacyclics LLC, An AbbVie Company $16.8606/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998290691 CMS
Merck Sharp & Dohme LLC $15.0206/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048815741 CMS
Daiichi Sankyo Inc. $13.9506/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006440663 CMS
Celgene Corporation $14.1606/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323883 CMS
Pharmacyclics LLC, An AbbVie Company $16.1906/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998290689 CMS
Eisai Inc. $16.9806/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023308137 CMS
Gilead Sciences, Inc. $17.8206/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025901347 CMS
E.R. Squibb & Sons, L.L.C. $0.8905/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323835 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.8505/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000505625 CMS
Merck Sharp & Dohme LLC $21.1905/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048549653 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.5605/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000501481 CMS
Genmab U.S., Inc. $13.9405/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343997 CMS
Celgene Corporation $13.6805/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323811 CMS
Eisai Inc. $17.6905/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023308135 CMS
E.R. Squibb & Sons, L.L.C. $14.7805/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323843 CMS
Seagen Inc. $14.1805/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995805890 CMS
Daiichi Sankyo Inc. $14.5005/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006442613 CMS
Merck Sharp & Dohme LLC $12.9104/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048549655 CMS
Gilead Sciences, Inc. $15.4704/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025980305 CMS
Celgene Corporation $15.0904/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323795 CMS
Merck Sharp & Dohme LLC $18.4704/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048887185 CMS
Janssen Biotech, Inc. $16.3104/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988335681 CMS
AVEO Pharmaceuticals, Inc. $20.9304/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049058215 CMS
Mirati Therapeutics, Inc. $15.4004/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057997347 CMS
Janssen Biotech, Inc. $14.5104/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988335669 CMS
Medtronic, Inc. $76.7404/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025799325 CMS
Sumitomo Pharma America, Inc. $14.6404/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030844661 CMS
Celgene Corporation $15.9304/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323787 CMS
Daiichi Sankyo Inc. $16.7903/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006339937 CMS
E.R. Squibb & Sons, L.L.C. $14.7003/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323778 CMS
AstraZeneca Pharmaceuticals LP $16.7403/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025051439 CMS
Janssen Biotech, Inc. $16.6003/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988335657 CMS
Pharmacyclics LLC, An AbbVie Company $16.9003/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998290687 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.7603/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000513597 CMS
E.R. Squibb & Sons, L.L.C. $16.2803/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323761 CMS
E.R. Squibb & Sons, L.L.C. $16.9803/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015323769 CMS
Lilly USA, LLC $16.1803/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031386829 CMS
Genmab U.S., Inc. $14.4503/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343993 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $517.55 30
PY2020 $305.47 15
PY2021 $956.57 60
PY2022 $1,666.30 103
PY2023 $1,998.11 120
PY2024 $7,419.73 147
PY2025 $8,896.44 123

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $124,507.64 15
PY2024 Principal investigator $92,439.80 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $2,415.93 12/31/2025 Covered Recipient Teaching Hospital
Atlanticare Regional Medical Center
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228708360
Principal investigator 1 PFIZER INC. $13,958.56 12/16/2025 Covered Recipient Teaching Hospital
Atlanticare Regional Medical Center
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228708358
Principal investigator 1 PFIZER INC. $30,805.26 11/20/2025 Non-covered Recipient Entity
AtlantiCare
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228714987
Principal investigator 1 PFIZER INC. $640.00 11/06/2025 Non-covered Recipient Entity
AtlantiCare
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228715163
Principal investigator 1 PFIZER INC. $46,207.89 11/06/2025 Non-covered Recipient Entity
AtlantiCare
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228715165
Principal investigator 1 Sumitomo Pharma America, Inc. $3,676.50 11/05/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601606
Principal investigator 1 Sumitomo Pharma America, Inc. $1,185.50 11/05/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601610
Principal investigator 1 Sumitomo Pharma America, Inc. $1,185.50 11/05/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601613
Principal investigator 1 PFIZER INC. $6,500.00 08/09/2025 Covered Recipient Teaching Hospital
Atlanticare Regional Medical Center
A PHASE 3 RANDOMIZED OPENLABEL STUDY OF PF06821497 MEVROMETOSTAT IN COMBINATION WITH ENZALUTAMIDE COMPARED WITH ENZALUTAMIDE OR DOCETAXEL IN PARTICIPANTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE MEVPRO1 No dispute reported 06/30/2026 1228708164
Principal investigator 1 Sumitomo Pharma America, Inc. $1,185.50 08/01/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601601
Principal investigator 1 Sumitomo Pharma America, Inc. $3,706.50 07/09/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601595
Principal investigator 1 Sumitomo Pharma America, Inc. $1,185.50 07/09/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601598
Principal investigator 1 Sumitomo Pharma America, Inc. $1,185.50 05/07/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601591
Principal investigator 1 Sumitomo Pharma America, Inc. $2,371.00 04/09/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601583
Principal investigator 1 Sumitomo Pharma America, Inc. $8,298.50 04/09/2025 Covered Recipient Teaching Hospital
ATLANTICARE REGIONAL MEDICAL CENTER
A MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY OF PATIENTS BEING TREATED WITH ORGOVYX No dispute reported 06/30/2026 1176601587